GSE115545
Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients.
Tumor-draining lymph node (TDLN) invasion by metastatic cells in breast cancer correlates with poor prognosis and is associated with local immunosuppression, which can be partly mediated by regulatory T cells (Tregs). Here, we study Tregs from matched tumor-invaded and non-invaded TDLNs, and breast tumors. We observe that Treg frequencies increase with nodal invasion, and express higher levels of co-inhibitory/stimulatory receptors than effector cells. Also, while Tregs show conserved suppressive function in TDLN and tumor, conventional T cells (Tconvs) in TDLNs proliferate and produce Th1-inflammatory cytokines, but are dysfunctional in the tumor. We describe a common transcriptomic signature shared by Tregs from tumors and nodes, including CD80, which is significantly associated with poor patient survival. TCR RNA-sequencing analysis indicates trafficking between TDLNs and tumors and ongoing Tconv/Treg conversion. Overall, TDLN Tregs are functional and express a distinct pattern of druggable co-receptors, highlighting their potential as targets for cancer immunotherapy. Overall design: TCR-ß sequencing of sorted CD4+ Tconv (CD4+FOXP3-CD45RA-) and Treg (CD4+FOXP3hiCD45RA-) from breast cancer patients. Tconvs and Tregs were purified and processed from matched non-invaded lymph node (N=5) and invaded lymph node (N=5), as well as tumors when possible (N=3 for Tconvs and N=2 for Tregs).